O165 Simeprevir Plus Sofosbuvir With/without Ribavirin in Hcv Genotype 1 Prior Null-responder/treatment-naive Patients (cosmos Study): Primary Endpoint (svr12) Results in Patients With Metavir F3–4 (cohort 2)
Year: 2014
Type: conference-abstract
Source: Journal of Hepatology
Authors: E. Lawitz, R. Ghalib, M. Rodriguez-Torres, Z.M. Younossi, A. Corregidor, M.S. Sulkowski, E. DeJesus, B. Pearlman, M. Rabinovitz, N. Gitlin, J.K. Lim, P.J. Pockros, B. Fevery, T. Lambrecht, S. Ouwerkerk-Mahadevan, K. Callewaert, W.T. Symonds, G. Picchio, K. Lindsay, M. Beumont-Mauviel, I.M. Jacobson
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1989522599